Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Feb 1;78(2):222-224.
doi: 10.1001/jamapsychiatry.2020.3000.

Effect of Escalating and Deescalating Financial Incentives vs Usual Care to Improve Antidepressant Adherence: A Pilot Randomized Clinical Trial

Steven C Marcus  1 , Megan E Reilly  2 , Kelly Zentgraf  2 , Kevin G Volpp  2 , Mark Olfson  3
Affiliations
Randomized Controlled Trial

Effect of Escalating and Deescalating Financial Incentives vs Usual Care to Improve Antidepressant Adherence: A Pilot Randomized Clinical Trial

Steven C Marcus et al. JAMA Psychiatry. .

Abstract

This pilot randomized clinical trial examines whether giving a financial incentive in an escalating or deescalating pattern (vs no incentive) to patients receiving antidepressants can enhance medication adherence.

Trial registration: ClinicalTrials.gov NCT03441399.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Volpp reported grants from National Institute of Mental Health during the conduct of the study; grants from Hawaii Medical Services Association, Vitality/Discovery, Humana, WW, and Oscar; personal fees from Center for Corporate Innovation, Lehigh Valley Medical Center, Vizient, Greater Philadelphia Business Coalition on Health, American Gastroenterological Association Tech Conference, Bridges to Population Health Meeting, and Irish Medtech Summit outside the submitted work; and being a part owner and consultant at VAL Health, a behavioral economics consulting firm. Dr Marcus reported grants from National Institute of Mental Health during the conduct of the study and personal fees from Allergan and Sage Therapeutics outside the submitted work. Dr Olfson reported grants from National Institute of Mental Health during the conduct of the study. No other disclosures were reported.

References

    1. Park LT, Zarate CA Jr. Depression in the primary care setting. N Engl J Med. 2019;380(6):559-568. doi:10.1056/NEJMcp1712493 - DOI - PMC - PubMed
    1. Silhan P, Urinovska R, Kacirova I, Hyza M, Grundmann M, Ceskova E. What does antidepressant drug level monitoring reveal about outpatient treatment and patient adherence? Pharmacopsychiatry. 2019;52(2):78-83. doi:10.1055/s-0044-101838 - DOI - PubMed
    1. Gudayol-Ferré E, Guàrdia-Olmos J, Peró-Cebollero M, et al. . Prediction of the time-course pattern of remission in depression by using clinical, neuropsychological, and genetic variables. J Affect Disord. 2013;150(3):1082-1090. doi:10.1016/j.jad.2013.04.024 - DOI - PubMed
    1. Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008;300(22):2631-2637. doi:10.1001/jama.2008.804 - DOI - PMC - PubMed
    1. Gopalan A, Shaw PA, Lim R, et al. . Use of financial incentives and text message feedback to increase healthy food purchases in a grocery store cash back program: a randomized controlled trial. BMC Public Health. 2019;19(1):674. doi:10.1186/s12889-019-6936-5 - DOI - PMC - PubMed

Publication types

Substances

Associated data